InvestorsHub Logo
Followers 7
Posts 496
Boards Moderated 0
Alias Born 11/15/2012

Re: Titan V post# 26622

Sunday, 11/30/2014 7:20:46 PM

Sunday, November 30, 2014 7:20:46 PM

Post# of 48316
ONCS is also working on identifying "biomarkers" which will help identify which patients will respond best.

So, they are working both ends of the desired solution, not just turning non-responders into responders.